Back to companies

Fresenius Kabi AG: Premium Databases

Fresenius Kabi AG Catalyst Calendar

Proactively evaluate Fresenius Kabi AG’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

A sample of Fresenius Kabi AG Catalyst Calendar data

Event Date Event Type Company Name Ticker Symbol Drug Name Therapy Area Indication Source Type
Showing 3 of 16+ results. Subscribe to unlock more.
13 Apr 2022 GDCTXXXX Lorem Lorem Lorem XXXX Planned Lorem
01 Dec 2021 Phase IV Trial Initiation Fresenius Kabi AG - SMOFlipid Gastrointestinal Liver Diseases Regulatory Website
01 Jul 2020 Phase II Trial Initiation Fresenius Kabi AG; Stellenbosch University - Aminoven Musculoskeletal Disorders Unspecified Musculoskeletal Disorders Clinical Trial Registry
17 Mar 2020 Phase I Trial Completion Fresenius Kabi SwissBioSim GmbH; PRA Health Sciences Inc - adalimumab biosimilar Dermatology; Gastrointestinal; Immunology; Musculoskeletal Disorders; Ophthalmology Ankylosing Spondylitis (Bekhterev's Disease); Crohn's Disease (Regional Enteritis); Hidradenitis Suppurativa; Plaque Psoriasis (Psoriasis Vulgaris); Polyarticular Juvenile Idiopathic Arthritis (PJIA); Psoriatic Arthritis; Rheumatoid Arthritis; Ulcerative Colitis; Uveitis Clinical Trial Registry
Catalyst Calendar

Feature

Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.

Benefit

Access:

  • Trial Events for trials conducted globally by a company, university, institute or CRO:  Trial Initiation, Trial Completion, Trial Results
  • Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
  • Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)

Value

Proactively evaluate companies and catalyst impacts

Stay ahead of the competition & improve corporate planning

Bolster business development with timely opportunities

Premium databases is part of our industry range of products

Subscribe to Company Analytics & gain 12-month access to premium industry data & analytics
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer